US5804399AExpiredUtility
Oncoprotein protein kinase
Est. expiryJul 19, 2013(expired)· nominal 20-yr term from priority
A61P 37/02A61P 9/08A61P 43/00A61P 9/10A61P 5/40A61P 37/00A61P 25/04A61P 31/12A61P 31/00C07K 16/40A61P 35/02A61K 38/00A61P 29/00A61P 35/00C12N 9/12
69
PatentIndex Score
16
Cited by
20
References
4
Claims
Abstract
An isolated polypeptide (JNK) characterized by having a molecular weight of 46 kD as determined by reducing SDS-PAGE, having serine and threonine kinase activity, phosphorylating the c-Jun N-terminal activation domain and polynucleotide sequences and method of detection of JNK are provided herein. JNK phosphorylates c-Jun N-terminal activation domain which affects gene expression from AP-1 sites.
Claims
exact text as granted — not AI-modifiedWe claim:
1. A method for identifying a composition which affects a kinase characterized as having a molecular weight of 55 kD as determined by reducing SDS-PAGE; having serine and threonine kinase activity; and phosphorylating the c-Jun N-terminal activation domain, comprising: a) incubating components comprising the composition and the kinase or polynucleotide encoding the kinase, wherein the incubating is carried out under conditions sufficient to allow the components to interact; and b) measuring the effect of the composition on the kinase or polynucleotide encoding the kinase.
2. The method of claim 1, wherein the effect is inhibition of the kinase.
3. The method of claim 1, wherein the effect is stimulation of the kinase.
4. The method of claim 1, wherein the composition is an immunosuppressing agent.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.